Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease

INTRODUCTION: The use of antipsychotic medications in Alzheimer's disease has been associated with an increased risk of mortality in clinical trials. However, an older postmortem literature suggests that those with schizophrenia treated in an era of exclusively conventional antipsychotic medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Koppel, Jeremy, Jimenez, Heidy, Adrien, Leslie, Greenwald, Blaine S., Marambaud, Philippe, Cinamon, Ezra, Davies, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644277/
https://www.ncbi.nlm.nih.gov/pubmed/29067299
http://dx.doi.org/10.1016/j.trci.2016.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644277/
https://www.ncbi.nlm.nih.gov/pubmed/29067299
http://dx.doi.org/10.1016/j.trci.2016.05.003

Ejemplares similares